Navigation Links
Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
Date:11/2/2010

and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause material differences include, among others, risks relating to: the successful preclinical development of our product candidates; the completion of our clinical trials; the review process of the FDA, the EMEA, other foreign regulatory bodies and other governmental regulatory bodies, including the FDA's and the EMEA's review of any filings we make in connection with the treatment protocol for taliglucerase alfa and including the risk that regulatory authorities may find that the data from our clinical trials and other studies is insufficient for regulatory approval; delays in the FDA's, the EMEA's or other health regulatory authorities' approval of any applications we file or refusals to approve such filings, including the NDA we filed with the FDA for taliglucerase alfa for the treatment of Gaucher disease; refusals by such regulatory authorities to approve the marketing and sale of a drug product even after acceptance of an application we file for any such drug product; and other factors described in our filings with the Securities and Exchange Commission. Companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in advanced or late-stage clinical trials, even after obtaining promising earlier trial results or in preliminary findings for such clinical trials. Further, even if favorable testing data is generated by clinical trials of drug products, the FDA, EMEA or any other foreign regulatory authority may not accept or approve an NDA filed by a pharmaceutical or biotechnology company for such drug product. Failure to obtain approval from the FDA, EMEA or any other foreign regulatory authority of any of our drug candidates in a timely
'/>"/>
SOURCE Protalix BioTherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
2. Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
3. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
4. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
5. Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
6. Talecris Biotherapeutics to Report Third Quarter 2010 Financial Results
7. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
8. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
9. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
10. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
11. Oxygen Biotherapeutics, Inc. Expands Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... May 27, 2015 The amount Americans spend ... 2014 and with growth of 8% will reach $608 ... of pocket: directly on expenditures, co-pays as part of ... on premiums.  The publisher made its finding in its ... the United States . ...
(Date:5/28/2015)... PORTLAND, Oregon , May 28, 2015 ... titled, "Global Syphilis Testing Market - Size, Industry Analysis, Trends, Opportunities, ... market to reach $3.6 billion by 2020. The secondary ... segment through 2020. Latin America , ... Africa (LAMEA) market accounted for about 43% ...
(Date:5/28/2015)...  Service Strategies Corp., a leading provider of ... a global healthcare company that specializes in lifesaving ... nutrition, has achieved certification under the prestigious ... the seventh consecutive year. The ... stringent set of performance criteria and represent the ...
Breaking Medicine Technology:Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 2Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 3
... Kan., May 21, 2012  BD (Becton, Dickinson and Company) ... technology company, and Heart to Heart International, a humanitarian ... second joint volunteer initiative to strengthen healthcare in Haiti.  ... world will build upon the progress made by their ...
... Inc. (NYSE MKT: INFU) ("InfuSystem" or the "Company"), the leading ... healthcare industry in the United States, today reported results for ... Revenues for the quarter ending March 31, 2012 were $14.3 ... of 2011.  Gross profit for the three months ending March ...
Cached Medicine Technology:BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti 2BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti 3InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 2InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 3InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 4InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 5InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 6InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 7InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 8InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 9
(Date:5/28/2015)... Senior Housing Assistance Group (SHAG) proudly announces a ... Seattle Mariners team that won a record tying 116 ... digital advertising for SHAG to help promote their affordable ... communities slated to open in the next 2 to ... and University Place. , Filming of new commercials starring ...
(Date:5/28/2015)... Jacksonville, Fla. (PRWEB) May 28, 2015 ... center dedicated to patients suffering from acute stroke or ... Emergency Medicine is one of a few in the ... and other neurological emergency needs such as brain aneurysms. ... facilities to take care of patients who are impacted ...
(Date:5/28/2015)... 28, 2015 Real Time Pain Relief ... products, today announced their best-selling lotion is now available in ... Relief is an FDA registered OTC pain relief product. It ... such as Aloe Vera, Arnica, Capsicum, Chondroitin, Emu Oil, Glucosamine, ... Menthol – only 1.25% – to avoid buildup of Substance ...
(Date:5/28/2015)... May 28, 2015 The Khanna Vision ... keratoconus web application to make learning about treatment ... the last few years. This proliferation of treatment techniques ... not aware of the nuances of the cutting edge ... realized that websites can be boring and printed material ...
(Date:5/28/2015)... 28, 2015 Optimity Advisors ( ... innovative models of care for healthcare organizations worldwide ... reimbursements and help operationalize contracting and engagement models. ... a bi-weekly series of seven “ OrangePapers” ... Contracting. Optimity is a strategy, operations and information ...
Breaking Medicine News(10 mins):Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2
... warns public that basketball is the only sport that ... 5,12,000 emergency cases related to basketball. ,‘So ... to take steps to reduce their injury risk,’ said ... University Health System, Maywood, Ill. ,‘Bicycles ...
... a friend or a relative learns that she has cancer ... this, than about herself//. Questions as to how should to ... normal for them during her treatment often assail her. ... Emotionally Healthy Child When a Parent is Sick (McGraw Hill, ...
... was set up by the Zambia Pharmaceutical Regulatory Authority (PRA). ... safety of medicines during the post marketing// surveillance process. Pharmaco, ... reactions due to a particular drug. This is to inculcate ... Minister Ronnie Shikapwasha launched the body on the 16th of ...
... Morris the present American tobacco giant says that smoking ... pro-smoking campaigners declare that smoking can fight disease //. ... these are the new marketing strategies, which the cigarette ... down the risks. Recently they have also extensively funded ...
... the latest medicine kings in the treatment of many complex ... in the June issue of Angiology if pine bark extract ... of muscles. ,The reason and scientific basis behind ... to the muscles which speeds recovery after physical exercise. ...
... at the University of California have found that even a ... the child's iron //reserves and offset anemia for months. ... and poor nations. It is a problem particularly in developing ... first year, putting them at risk of serious developmental problems ...
Cached Medicine News:Health News:Basketball Top For Injurious Sports 2Health News:Basketball Top For Injurious Sports 3Health News:Helping a Family Going Through an Illness 2Health News:So Called Benefits of Nicotine 2Health News:A herbal delight for athletes in solving cramp and pain problems 2Health News:A herbal delight for athletes in solving cramp and pain problems 3Health News:Infants have better iron reserves if umbilical cord clamping is delayed 2Health News:Infants have better iron reserves if umbilical cord clamping is delayed 3
... MOBEE headboxes are the ... line of portable battery-powered ... a robust new mechanical ... software, XLTEK's standard MOBEE24plus ...
... Slit Lamp is an all-in-one instrument for observation, ... also allows the SL 130 to be used ... the possibility of operating the slit projector in ... right hand. The instrument configuration allows you to ...
... Lens Analyzers Model 350 and Model ... comprehensive lensometry for your practice. ,Simple ... (LA) gives fast and accurate lens ... prism lenses, contact lenses, polycarbonate and ...
... Bausch & Lomb provides fingertip control with ... handed delivery of the IOL directly into ... is assured by planar delivery. Leading haptic ... the capsular bag without sweeping motion. No ...
Medicine Products: